KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Share-based Compensation (2016 - 2025)

Globus Medical's Share-based Compensation history spans 15 years, with the latest figure at $11.4 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 4.11% year-over-year to $11.4 million; the TTM value through Dec 2025 reached $49.8 million, down 8.14%, while the annual FY2025 figure was $49.8 million, 8.14% down from the prior year.
  • Share-based Compensation reached $11.4 million in Q4 2025 per GMED's latest filing, down from $11.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $22.8 million in Q3 2023 to a low of $7.5 million in Q3 2021.
  • Average Share-based Compensation over 5 years is $11.0 million, with a median of $10.2 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: surged 173.69% in 2023, then plummeted 46.34% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $7.8 million in 2021, then increased by 8.99% to $8.5 million in 2022, then skyrocketed by 46.29% to $12.4 million in 2023, then dropped by 4.32% to $11.9 million in 2024, then dropped by 4.11% to $11.4 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Share-based Compensation are $11.4 million (Q4 2025), $11.5 million (Q3 2025), and $13.6 million (Q2 2025).